Steve Miller, Chief Op. & Scientific Officer at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 115,000 shares at $20.28 ($2.3M) on 2025-08-26, disclosed to the SEC on 2025-08-28.
Open-market sale of $2.3M CPRX by Chief Op. & Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CPRX | SELL | 2023-12-07 | $570K | — | Filing → |
| CPRX | SELL | 2022-11-23 | $1.6M | — | Filing → |
| CPRX | SELL | 2022-09-15 | $2.4M | — | Filing → |